Azacitidine 100Mg Injection

* To be consumed as directed by physician.

Azacitidine 100Mg Injection

Azacitidine IP 100Mg
Azacitidine belongs to anti-cancer therapy of Oncology Division.
Azashine is indicated for treatment of patients with the myelodysplastic syndrome subtypes: Refractory anemia or refractory anemia with ringed sideroblasts, Refractory anemia with excess blasts, in transformation, and chronic myelomonocytic leukemia.
(4.6 Rating)

Product Enquiry

Send Message